Maryam Dolatshahi, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Research they published
5 papers · cited 104 times
Published as Maryam Dolatshahi at University of California, Davis.
Research identity is not a guarantee of current clinical practice. Same name is not the same person — if this looks like someone else, tell us.
| 2023 | Gastric cancer and mesenchymal stem cell-derived exosomes: from pro-tumorigenic effects to anti-cancer vehiclesFirst author | Archives of Pharmacal Research |
| 2009 | Epigenetic Regulation of Hepatic Endoplasmic Reticulum Stress Pathways in the Ethanol-Fed Cystathionine Beta Synthase–Deficient Mouse | Hepatology |
Topics: Extracellular vesicles in disease · Bone Tissue Engineering Materials · Mesenchymal stem cell research · Epigenetics and DNA Methylation · Cancer Cells and Metastasis
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dolatshahi’s office at (408) 445-4010 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Original Medicare doctor bills
$14,173
Medicare paid this office $14,173 for 40 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 22 | $7,922 | $169 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,995 | $158 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 13 | $433 | $15 |
Who their Medicare patients are
40 Original Medicare patients in 2024. Average age 75 · Health risk score 0.86. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 70%.
The office billed $37,623, Medicare allowed $17,538 and paid $14,173; for 130 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 40 | 130 | 75 | 0.86 | $37,623 | $14,173 |
| 2023 | 63 | 213 | 75 | 0.89 | $74,512 | $28,896 |
| 2022 | 59 | 157 | 73 | 0.74 | $44,540 | $19,089 |
| 2021 | 51 | 115 | 75 | 0.89 | $37,862 | $13,235 |
| 2020 | 63 | 164 | 74 | 0.83 | $35,826 | $13,194 |
| 2019 | 67 | 130 | 74 | 0.83 | $32,103 | $10,471 |
| 2018 | 91 | 246 | 70 | 0.69 | $56,728 | $18,970 |
| 2017 | 21 | 43 | 71 | 0.72 | $8,421 | $2,818 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 32 | $17,154 | $165 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $4,308 | $160 |
| Return visit (30+ min) | 21 | $2,322 | $93 |
| Short return visit (20+ min) | 14 | $1,246 | $89 |
2022: 4 services
| Long return visit (40+ min) | 23 | $6,736 | $157 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $4,878 | $157 |
| Return visit (30+ min) | 25 | $3,107 | $111 |
| Short return visit (20+ min) | 17 | $1,680 | $80 |
2021: 4 services
| Long return visit (40+ min) | 26 | $4,836 | $138 |
| Return visit (30+ min) | 31 | $4,416 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,184 | $146 |
| Short return visit (20+ min) | 13 | $812 | $54 |
2020: 2 services
| Return visit (30+ min) | 36 | $5,070 | $89 |
| Short return visit (20+ min) | 30 | $2,496 | $71 |
2019: 4 services
| Return visit (30+ min) | 34 | $3,243 | $68 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,921 | $137 |
| Short return visit (20+ min) | 17 | $688 | $40 |
| Administration of pneumococcal vaccine | 11 | $226 | $21 |
2018: 7 services
| Return visit (30+ min) | 43 | $6,879 | $91 |
| Short return visit (20+ min) | 33 | $2,169 | $47 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,445 | $131 |
| New patient visit (30+ min) | 12 | $813 | $68 |
| Influenza vaccine split virus, preservative free | 15 | $648 | $43 |
| Administration of influenza virus vaccine | 17 | $437 | $26 |
| Administration of pneumococcal vaccine | 13 | $334 | $26 |
Drugs they prescribed that Part D paid
$21,645
Pharmacies billed $21,645 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (28 of 649) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
623 generic and 26 brand-name prescriptions · $21,645 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 66 | $693 | $10 |
| Amlodipine Besylate | 37 | $531 | $14 |
| Levothyroxine | 38 | $438 | $12 |
| Venlafaxine Hcl Er | 20 | $327 | $16 |
| Losartan | 24 | $311 | $13 |
See all 16 drugs
| Atorvastatin | 66 | $693 | $10 |
| Amlodipine Besylate | 37 | $531 | $14 |
| Levothyroxine | 38 | $438 | $12 |
| Venlafaxine Hcl Er | 20 | $327 | $16 |
| Losartan | 24 | $311 | $13 |
| Gabapentin | 14 | $296 | $21 |
| Isosorbide Mononitrate Er | 12 | $252 | $21 |
| Diltiazem | 12 | $252 | $21 |
| Simvastatin | 12 | $251 | $21 |
| Rosuvastatin | 16 | $217 | $14 |
| Clonazepam | 13 | $167 | $13 |
| Fluticasone Propionate | 16 | $159 | $10 |
| Lisinopril | 15 | $95 | $6 |
| Atenolol | 17 | $94 | $6 |
| Tramadol | 11 | $76 | $7 |
| Hydrochlorothiazide | 17 | $63 | $4 |
Year by year
| 2024 | 649 | 69 | 4% (28) | 4% | $21,645 |
| 2023 | 747 | 75 | 4% (26) | None | $38,110 |
| 2022 | 572 | 66 | None | None | $35,399 |
| 2021 | 612 | 70 | None | 12% | $31,860 |
| 2020 | 556 | 76 | None | None | $39,777 |
| 2019 | 631 | 74 | None | None | $146,723 |
| 2018 | 421 | 64 | 4% (16) | 18% | $76,392 |
| 2017 | 196 | 51 | None | 27% | $20,437 |
| 2016 | 152 | 54 | None | None | $10,440 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Atorvastatin | 58 | $979 | $17 |
| Mirtazapine | 20 | $826 | $41 |
| Levothyroxine | 34 | $669 | $20 |
| Tramadol | 16 | $504 | $32 |
| Venlafaxine Hcl Er | 18 | $437 | $24 |
| Diltiazem | 12 | $387 | $32 |
| Gabapentin | 26 | $386 | $15 |
| Lisinopril | 22 | $378 | $17 |
| Losartan | 15 | $372 | $25 |
| Amlodipine Besylate | 29 | $355 | $12 |
| Fluticasone Propionate | 14 | $337 | $24 |
| Nitrofurantoin Mono-Macro | 12 | $323 | $27 |
| Clonazepam | 17 | $283 | $17 |
| Isosorbide Mononitrate Er | 12 | $252 | $21 |
| Metoprolol | 11 | $209 | $19 |
| Famotidine | 15 | $179 | $12 |
| Alprazolam | 16 | $176 | $11 |
| Atenolol | 11 | $168 | $15 |
| Lovastatin | 12 | $116 | $10 |
| Lorazepam | 14 | $64 | $5 |
| Hydrochlorothiazide | 19 | $46 | $2 |
2022: 9 drugs
| Atorvastatin | 45 | $489 | $11 |
| Levothyroxine | 36 | $468 | $13 |
| Venlafaxine Hcl Er | 21 | $111 | $5 |
| Montelukast | 14 | $110 | $8 |
| Lisinopril | 19 | $109 | $6 |
| Lovastatin | 12 | $92 | $8 |
| Amlodipine Besylate | 18 | $92 | $5 |
| Clonazepam | 11 | $65 | $6 |
| Hydrochlorothiazide | 16 | $42 | $3 |
2021: 14 drugs
| Xarelto | 12 | $6,204 | $517 |
| Rosuvastatin | 13 | $1,836 | $141 |
| Levothyroxine | 45 | $742 | $16 |
| Atorvastatin | 40 | $612 | $15 |
| Lovastatin | 25 | $346 | $14 |
| Fluticasone Propionate | 15 | $345 | $23 |
| Amlodipine Besylate | 29 | $246 | $8 |
| Clonazepam | 13 | $198 | $15 |
| Trazodone | 16 | $183 | $11 |
| Lisinopril | 15 | $167 | $11 |
| Simvastatin | 15 | $131 | $9 |
| Hydrochlorothiazide | 18 | $116 | $6 |
| Metoprolol | 13 | $105 | $8 |
| Atenolol | 11 | $71 | $6 |
2020: 9 drugs
| Eliquis | 17 | $16,215 | $954 |
| Levothyroxine | 47 | $879 | $19 |
| Atorvastatin | 40 | $510 | $13 |
| Lovastatin | 28 | $389 | $14 |
| Simvastatin | 25 | $305 | $12 |
| Lisinopril | 20 | $160 | $8 |
| Amlodipine Besylate | 28 | $154 | $5 |
| Hydrochlorothiazide | 20 | $112 | $6 |
| Atenolol | 12 | $96 | $8 |
2019: 14 drugs
| Flovent Hfa | 15 | $6,947 | $463 |
| Duloxetine | 13 | $900 | $69 |
| Levothyroxine | 32 | $755 | $24 |
| Gabapentin | 13 | $697 | $54 |
| Atorvastatin | 29 | $552 | $19 |
| Rosuvastatin | 11 | $475 | $43 |
| Lovastatin | 27 | $349 | $13 |
| Simvastatin | 26 | $306 | $12 |
| Amlodipine Besylate | 23 | $265 | $12 |
| Alendronate | 17 | $208 | $12 |
| Lisinopril | 24 | $206 | $9 |
| Atenolol | 15 | $160 | $11 |
| Hydrochlorothiazide | 19 | $90 | $5 |
| Clonazepam | 13 | $68 | $5 |
2018: 10 drugs
| Flovent Hfa | 12 | $6,088 | $507 |
| Levothyroxine | 16 | $446 | $28 |
| Lovastatin | 12 | $200 | $17 |
| Spironolactone | 13 | $198 | $15 |
| Gabapentin | 11 | $188 | $17 |
| Clonazepam | 15 | $150 | $10 |
| Fluoxetine | 11 | $117 | $11 |
| Lisinopril | 20 | $114 | $6 |
| Amlodipine Besylate | 16 | $72 | $5 |
| Hydrochlorothiazide | 14 | $53 | $4 |
2017: 4 drugs
| Atorvastatin | 20 | $219 | $11 |
| Amlodipine Besylate | 17 | $84 | $5 |
| Lisinopril | 15 | $83 | $6 |
| Fluticasone Propionate | 11 | $83 | $8 |
2016: 1 drug
| Lisinopril | 17 | $81 | $5 |
Professional record
- NPI
- 1992053581
- Trained
- University of California, Davis School of Medicine, 2014
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 455 Oconnor Dr Ste 250, San Jose, CA, 95128
- NPI first listed
- 2012-08-29
- NPI last updated
- 2014-06-17
This is when the NPI record was last certified, not a medical board exam.